Ratio Therapeutics and Ionetix have inked separate deals to boost production of the much-needed radioisotope actinium-225, ...

The financing round was jointly led by new investor Regeneron Ventures and current investor Deerfield Management.

Crispr Therapeutics AG leverages CASGEVY's rollout, a robust pipeline in cardiovascular, oncology, & partnerships to large ...

Crispr announced a collaboration with Sirius Therapeutics to work on multiple ... it provides synergies for Crispr’s cardiovascular pipeline candidates with large market potential.

Vigil’s pipeline, led by its small molecule TREM2 agonist for ... It has joined forces with Chinese-American Sirius Therapeutics to co-develop and co-commercialize the siRNA SRSD107 to treat ...

The strategic partnership is likely to diversify CRISPR Therapeutics’ pipeline by adding Sirius’s lead candidate, SRSD107, a next-generation, long-acting siRNA therapy, which is being ...

Sirius’ siRNA platform complements ... any or all of the following: (i) CRISPR Therapeutics preclinical studies, clinical trials and pipeline products and programs, including, without limitation ...

The strategic partnership is likely to diversify CRISPR Therapeutics’ pipeline by adding Sirius’s lead candidate, SRSD107, a next-generation, long-acting siRNA therapy, which is being developed in ...